AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Pharmaceutical Companies

683.947

+0.7470.11%

Number of Gainers:19

Number of Losers:5

Number of Flat:21

PE:- -

High:691.975

Open:684.744

Low:682.775

Close:683.200

Volume:36.26M

Turnover:94.15M

Market Cap:102.25B

Float Cap:98.92B

Loading ...

Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Index Up 4.5% for Week

MT Newswires Live

Imugene and JW Therapeutics Partner to Advance CAR-T and Oncolytic Virus Therapy for Solid Tumors

Imugene and Jw Therapeutics Announce a Collaboration to Advance Oncarlytics and Carteyva® Combination in Solid Tumours

THOMSON REUTERS

BUZZ-Australia's Monash IVF eyes best week in 5-1/2 years after rejecting takeover bid

Profitable, cashed-up and cheap - one of the stocks grabbing this small cap investor's attention

Cann Group Ltd-Chair's Address to Shareholders

THOMSON REUTERS

Monash Says Victorian Department of Health Determines Imposition of Conditions for Registrations of Victoria Clinics

MT Newswires Live

Monash IVF Group Ltd - Conditions Arise Following Incident at Clayton Laboratory

THOMSON REUTERS

Monash IVF Group Ltd - Victorian Department of Health Has Determined to Impose Certain Conditions on Registrations of Co's Clinics in Victoria

THOMSON REUTERS

Monash IVF Group Ltd - Process Changes Required Under Conditions Have Already Been Implemented by Company

THOMSON REUTERS

Monash IVF Group Ltd - Does Not Expect That Conditions Will Have a Material Impact on Existing Operations

THOMSON REUTERS

Australian shares close marginally higher; tech shines, commodity stocks dip

Imugene Partners With Chinese Biotechnology Company to Trial Combination Therapy in Refractory Solid Tumors; Shares Up 3%

MT Newswires Live

BRIEF-Imugene Signs Strategic Collaboration With JW Therapeutics

BUZZ-Australia's Imugene gains on alliance with JW Therapeutics for tumour treatment

Alan Kohler: The grass is always greener on the other side

We're Not Very Worried About Proteomics International Laboratories' (ASX:PIQ) Cash Burn Rate

Simply Wall St.

Is Imricor Medical Systems (ASX:IMR) Using Debt In A Risky Way?

Simply Wall St.

Imugene Ltd - Collaboration to Advance Oncarlytics and Carteyva Combination in Solid Tumours

THOMSON REUTERS

Imugene Ltd-Strategic Collaboration With Jw Therapeutics

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK7508/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":683.94653,"timestamp":1764305999920,"preClose":683.1998,"halted":0,"volume":36263776,"delay":0,"changeRate":0.001093,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":0.746704,"latestTime":"11-28 16:00:00 AEDT","open":684.7437,"high":691.9752,"low":682.7754,"amount":94147851,"amplitude":0.013466,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1764543600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1764284400000,1764306000000]],"turnoverRate":0.001393,"increases":18,"decrements":6,"flats":20,"marketCap":102252356698,"floatMarketCap":98921583918.9375},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":691.9752,"amplitude":0.013466,"preClose":683.1998,"low":682.7754,"latestPrice":683.94653,"volume":36263776,"delay":0,"open":684.7437,"prevYearClose":936.801,"prevWeekClose":683.947,"prevMonthClose":683.947,"prevQuarterClose":712.826,"fiveDayClose":654.211,"twentyDayClose":662.953,"sixtyDayClose":747.652,"secType":"PLATE","market":"AU","turnoverRate":0.001393,"marketCap":102252356698,"floatMarketCap":98921583918.9375,"timestamp":1764305999920,"nameCN":"Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":19,"down":5,"flat":21},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2586611736","title":"Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Index Up 4.5% for Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2586611736","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586611736?lang=en_us&edition=fundamental","pubTime":"2025-11-28 23:53","pubTimestamp":1764345206,"startTime":"0","endTime":"0","summary":"Asian equities traded in the US as American depositary receipts were up Friday morning, rising 0.29% to 2,683.52 on the S&P Asia 50 ADR Index, which has gained 4.5% for the week.From North Asia, the gainers were led by health platform 111  and mobile Cheetah Mobile , which climbed 10% and 6.5% respectively. They were followed byComputer hardware Canaan  and online video streaming service iQIYI , which increased 4.8% and 4.4% respectively.The decliners from North Asia were led by mobile big data platform Aurora Mobile  and automotive marketplace Token Cat , which were down 2.9% and 2.3% respectively. They were followed by game-centric live streaming platform DouYu International  and used car marketplace Uxin , which were dropped 1.6%  each.From South Asia, the gainers were led by tech conglomerate Sea  and lender ICICI Bank , which increased 3.1% and 1.1% respectively. They were followed by lender HDFC Bank  and IT firm Infosys , which were up 0.9% and 0.8% respectively.The only decline","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4134","PHI","AFG","TC","LU0289960550.SGD","YI","SG9999006266.SGD","BK4023","LU0348814723.USD","LU1791710400.SGD","BK7508","LU0348788117.USD","LU1791710582.SGD","SG9999014484.SGD","BK4220","LU0261945553.USD","LU1861220207.SGD","JG","LU2065171402.SGD","LU2087589342.USD","HDB","IE0034224299.USD","LU0164881194.USD","LU0516422366.SGD","BK4122","LU0175139822.USD","TLK","LU0541502299.USD","CMCM","SG9999005177.SGD","UXIN","BK4509","LU0181495838.USD","CAN.AU","IBN","SG9999002620.SGD","SG9999014039.USD","LU0345776255.USD","CAN","DOYU","LU0348816934.USD","LU0918141705.HKD","SE","LU2045819591.USD","INFY","IQ","LU2065171311.SGD","SG9999002406.SGD","LU1242518857.USD","BK4207"],"gpt_icon":1},{"id":"2586208061","title":"Imugene and JW Therapeutics Partner to Advance CAR-T and Oncolytic Virus Therapy for Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2586208061","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586208061?lang=en_us&edition=fundamental","pubTime":"2025-11-28 13:01","pubTimestamp":1764306071,"startTime":"0","endTime":"0","summary":"Imugene Limited has announced a strategic collaboration with JW Therapeutics to advance a novel combination therapy for refractory solid tumors. The partnership will evaluate Imugene's onCARlytics  oncolytic virus in combination with JW Therapeutics' Carteyva, an approved CD19-directed autologous CAR-T cell therapy. The initiative includes preclinical studies and a Phase 1 investigator-initiated trial in China, employing a \"mark and kill\" strategy where the oncolytic virus induces CD19 expression on tumor cells, making them targetable by CAR-T cells. The collaboration aims to generate impactful preclinical and clinical data to explore new treatment paradigms for solid tumors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Imugene Limit","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251128:nNDL6XF6wh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","02126","BK7067","BK7508","BK1583","IMU.AU","BK1161"],"gpt_icon":0},{"id":"2586208704","title":"Imugene and Jw Therapeutics Announce a Collaboration to Advance Oncarlytics and Carteyva® Combination in Solid Tumours","url":"https://stock-news.laohu8.com/highlight/detail?id=2586208704","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586208704?lang=en_us&edition=fundamental","pubTime":"2025-11-28 13:00","pubTimestamp":1764306025,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251128:nTUA38GFTS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","IMU.AU","BK7508"],"gpt_icon":0},{"id":"2586208146","title":"BUZZ-Australia's Monash IVF eyes best week in 5-1/2 years after rejecting takeover bid","url":"https://stock-news.laohu8.com/highlight/detail?id=2586208146","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586208146?lang=en_us&edition=fundamental","pubTime":"2025-11-28 12:42","pubTimestamp":1764304920,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Monash IVF eyes best week in 5-1/2 years after rejecting takeover bid** Shares of Monash IVF Group MVF.AX rise 40.1% so far this week, heading for best week since mid-April 2020, if gains hold** For the day, the IVF clinics operator down 0.3% at A$0.848 but hovers near highest since mid-May hit on Monday** On Monday, co rejected a conditional and non-binding takeover proposal from a consortium including Genesis Capital Investment Management** Proposal was at a \"substantial discount to comparable IVF transactions in the Australian market\" - MVF** Stock down ~33% YTD, including day's moves  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251128:nL6N3X4062:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","MVF.AU","BK7113"],"gpt_icon":0},{"id":"2586275219","title":"Profitable, cashed-up and cheap - one of the stocks grabbing this small cap investor's attention","url":"https://stock-news.laohu8.com/highlight/detail?id=2586275219","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586275219?lang=en_us&edition=fundamental","pubTime":"2025-11-28 07:30","pubTimestamp":1764286204,"startTime":"0","endTime":"0","summary":"Some weeks in markets serve as a sharp reminder that efficiency is more theory than reality. Trading updates slip past unnoticed, stocks rally on headlines that don’t justify the move, and genuine value quietly appears in places most investors stopped looking.This past week has been exactly that kind of week: pockets of mispricing, takeover intrigue, and the sort of behavioural quirks that make the ASX both endlessly fascinating and occasionally baffling.Ben Richards, Co-Portfolio Manager of the Australian Shares and Australian Small Companies Fund at Seneca Financial Solutions, spends his days operating squarely in that gap between sentiment and fundamentals.It’s a role that rewards curiosity and demands it, and this week offered no shortage of moments that challenged and clarified his thinking.We bought more Euroz Hartleys  stock this week.Something that caught my eye was this AFR Street talk article, noting that Healthscope got removed from 12 properties as a tenant, which we think ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/profitable-cashed-up-and-cheap-one-of-the-stocks-grabbing-this-small-cap-investor-s-attention","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/profitable-cashed-up-and-cheap-one-of-the-stocks-grabbing-this-small-cap-investor-s-attention","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["XAO.AU","BK4588","EZL.AU","XJO.AU","BK4555","BK7503","BK7149","HCW.AU","BK7005","EOL.AU","BK7016","BK7062","WTC.AU","BK7156","BK7162","BK7054","DRO.AU","XKO.AU","BK4585","BK4099","BK7113","BK7115","MVF.AU","BK7508"],"gpt_icon":0},{"id":"2586627396","title":"Cann Group Ltd-Chair's Address to Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2586627396","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586627396?lang=en_us&edition=fundamental","pubTime":"2025-11-28 07:29","pubTimestamp":1764286196,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251127:nTUE5GGZNL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CAN.AU","BK7096","BK7502","BK7508"],"gpt_icon":0},{"id":"2586027847","title":"Monash Says Victorian Department of Health Determines Imposition of Conditions for Registrations of Victoria Clinics","url":"https://stock-news.laohu8.com/highlight/detail?id=2586027847","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586027847?lang=en_us&edition=fundamental","pubTime":"2025-11-28 06:44","pubTimestamp":1764283492,"startTime":"0","endTime":"0","summary":"Monash IVF Group  said the Victorian Department of Health has determined to impose certain conditions on the registrations of its clinics in Victoria, after the embryo transfer mix-up at its Clayton lab, with the action effective Friday, according to a same-day filing with the Australian bourse.The conditions includes steps to verify the intended biological sources for each cycle, requirements for patient-management system, witnessing, checking and record-keeping, the filing said.The company said it does not expect the conditions to materially affect its operations or alter its earnings guidance, the filing added.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NPL.SI","BK7508","VCCTF","BK4095","BK6100","BK7113","MVF.AU"],"gpt_icon":0},{"id":"2586639220","title":"Monash IVF Group Ltd - Conditions Arise Following Incident at Clayton Laboratory","url":"https://stock-news.laohu8.com/highlight/detail?id=2586639220","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586639220?lang=en_us&edition=fundamental","pubTime":"2025-11-28 05:24","pubTimestamp":1764278661,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251127:nFWN3X30N0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MVF.AU","BK7508","BK7113"],"gpt_icon":0},{"id":"2586220636","title":"Monash IVF Group Ltd - Victorian Department of Health Has Determined to Impose Certain Conditions on Registrations of Co's Clinics in Victoria","url":"https://stock-news.laohu8.com/highlight/detail?id=2586220636","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586220636?lang=en_us&edition=fundamental","pubTime":"2025-11-28 05:24","pubTimestamp":1764278661,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251127:nFWN3X30N0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MVF.AU","BK7508","BK7113"],"gpt_icon":0},{"id":"2586206352","title":"Monash IVF Group Ltd - Process Changes Required Under Conditions Have Already Been Implemented by Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2586206352","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586206352?lang=en_us&edition=fundamental","pubTime":"2025-11-28 05:24","pubTimestamp":1764278661,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251127:nFWN3X30N0:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MVF.AU","BK7508","BK7113"],"gpt_icon":0},{"id":"2586122063","title":"Monash IVF Group Ltd - Does Not Expect That Conditions Will Have a Material Impact on Existing Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=2586122063","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586122063?lang=en_us&edition=fundamental","pubTime":"2025-11-28 05:24","pubTimestamp":1764278661,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251127:nFWN3X30N0:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7113","MVF.AU","BK7508"],"gpt_icon":0},{"id":"2586211063","title":"Australian shares close marginally higher; tech shines, commodity stocks dip","url":"https://stock-news.laohu8.com/highlight/detail?id=2586211063","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586211063?lang=en_us&edition=fundamental","pubTime":"2025-11-27 14:37","pubTimestamp":1764225422,"startTime":"0","endTime":"0","summary":"Australian shares close marginally higher; tech shines, commodity stocks dipUpdates to closeAXJO rises for a fourth straight sessionTech gains 2%, the energy sub-index falls 1.3%NZ50 ends 1% lowerBy Keshav SinghChundawat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251127:nL4N3X309K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0266512127.USD","LU0788109121.HKD","LU0612318971.USD","BK7016","RIO.UK","BK5111","BK7503","LU1064927863.SGD","LU0505663152.USD","LU0654597011.USD","LU0330918003.SGD","BK7095","CSL.AU","LU0456854461.SGD","BK7067","BK7142","BK7034","LU0612318385.USD","LU1430597077.USD","BK7501","LU0075056555.USD","WDS.AU","QBE.AU","IE00B3M56506.USD","IE0034235071.USD","WTC.AU","LU2463526074.USD","LU0630314457.HKD","LU0345777659.USD","LU0345780950.USD","LU0898667661.SGD","IE00BQJZX424.USD","LU1078025761.USD","LU0831103253.SGD","LU1023059493.AUD","LU0171293334.USD","LU0345777147.USD","LU0161305163.EUR","LU0345781412.USD","SG9999002521.SGD","LU0955669360.SGD","SG9999001143.SGD","BK7508","IE00BWDBJ516.SGD","LU0011963245.USD","LU0266512473.USD","BK7511","LU1130305938.SGD","BK7507","BHP.AU"],"gpt_icon":0},{"id":"2586829060","title":"Imugene Partners With Chinese Biotechnology Company to Trial Combination Therapy in Refractory Solid Tumors; Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586829060","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586829060?lang=en_us&edition=fundamental","pubTime":"2025-11-27 10:37","pubTimestamp":1764211066,"startTime":"0","endTime":"0","summary":"Imugene  partnered with biotechnology company JW Therapeutics  to assess the combination therapy of the company's oncolytic virus CF33-CD19, onCARlytics, and JW's CD19 CAR-T cell therapy, Carteyva, in patients with advanced solid tumors, according to a Thursday filing with the Australian bourse.The collaboration involves preclinical studies, both in vitro and in vivo, leading to a first-phase investigator-initiated trial conducted in China, the filing said.Imugene shares rose 3% in afternoon trade on Thursday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMU.AU","BK7067","BK7508"],"gpt_icon":0},{"id":"2586973862","title":"BRIEF-Imugene Signs Strategic Collaboration With JW Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2586973862","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586973862?lang=en_us&edition=fundamental","pubTime":"2025-11-27 09:56","pubTimestamp":1764208593,"startTime":"0","endTime":"0","summary":"BRIEF-Imugene Signs Strategic Collaboration With JW TherapeuticsNov 27 (Reuters) - Imugene Ltd IMU.AX:STRATEGIC COLLABORATION WITH JW THERAPEUTICSCOLLABORATION TO ADVANCE ONCARLYTICS AND CARTEYVA COMBINATION IN SOLID TUMOURSFurther company coverage: IMU.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251127:nTUE6YR8Y7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7067","IMU.AU"],"gpt_icon":0},{"id":"2586946912","title":"BUZZ-Australia's Imugene gains on alliance with JW Therapeutics for tumour treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2586946912","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586946912?lang=en_us&edition=fundamental","pubTime":"2025-11-27 09:04","pubTimestamp":1764205483,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Imugene gains on alliance with JW Therapeutics for tumour treatment** Shares of Imugene IMU.AX rise as much as 6.2% to A$0.345, the highest since November 6** The biotechnology compan","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251127:nL4N3X302I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","IMU.AU","02126","BK7508","BK1583","BK1161","BK7067"],"gpt_icon":0},{"id":"2586299378","title":"Alan Kohler: The grass is always greener on the other side","url":"https://stock-news.laohu8.com/highlight/detail?id=2586299378","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586299378?lang=en_us&edition=fundamental","pubTime":"2025-11-27 08:30","pubTimestamp":1764203407,"startTime":"0","endTime":"0","summary":"Investors are hardwired to compare themselves with whatever is running hottest at the time. When US tech stocks roar, the temptation is to look at the ASX and wonder why we bother. Yet Alan Kohler, one of the most recognisable voices in Australian finance, is entirely at ease with the slower and steadier returns on home soil. And after decades watching market cycles come and go, he has a simple message for anyone feeling twitchy about missing out.“We probably shouldn’t get too greedy,” he says.The local market has delivered a modest gain this year, but once you factor in dividends, total returns are north of 7 percent with a month still to run.It feels unremarkable only when stacked against the US, where the S&P 500 has surged on the back of an AI-fuelled boom. But Kohler’s view is that the extra sizzle in the US comes with baggage that many investors tend to forget until it is too late.Nvidia continues to deliver big numbers, but the market is slowly realising that its customer","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/alan-kohler-the-grass-is-always-greener-on-the-other-side","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/alan-kohler-the-grass-is-always-greener-on-the-other-side","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["LU0683600562.USD","RMD.AU","NVDS.UK","LU0203202063.USD","NVDA","LU2473716301.USD","NVDS","LU1868836591.USD","NVDY","LU2592432038.USD","LU2244417387.USD","LU2125909247.SGD","NVD2.UK","2NVD.UK","LMG.AU","XAO.AU","SRL.AU","LU0466842654.USD","LU2413666699.HKD","ARU.AU","LU1935043023.USD","NVIW.SI","XJO.AU","LU2108987350.USD","3NVD.UK","LU1116320737.USD","LU0689626769.HKD","LU1934455277.USD","COH.AU","BK7508","NVD3.UK","NVDD","BK4567","LU1066051498.USD","NVD","IE00BDCRKT87.USD","BK4579","LU2750360641.GBP","LU1551013342.USD","SNVD.UK","LU0342679015.USD","XKO.AU","NVDU","LU1267930730.SGD","BK4554","LU0345770308.USD","LU1815333072.USD","CSL.AU"],"gpt_icon":1},{"id":"2586299927","title":"We're Not Very Worried About Proteomics International Laboratories' (ASX:PIQ) Cash Burn Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2586299927","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586299927?lang=en_us&edition=fundamental","pubTime":"2025-11-27 07:52","pubTimestamp":1764201165,"startTime":"0","endTime":"0","summary":"Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-piq/proteomics-international-laboratories-shares/news/were-not-very-worried-about-proteomics-international-laborat","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-piq/proteomics-international-laboratories-shares/news/were-not-very-worried-about-proteomics-international-laborat","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7048","PIQ.AU","BK7508"],"gpt_icon":0},{"id":"2586299905","title":"Is Imricor Medical Systems (ASX:IMR) Using Debt In A Risky Way?","url":"https://stock-news.laohu8.com/highlight/detail?id=2586299905","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586299905?lang=en_us&edition=fundamental","pubTime":"2025-11-27 07:20","pubTimestamp":1764199234,"startTime":"0","endTime":"0","summary":"Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-imr/imricor-medical-systems-shares/news/is-imricor-medical-systems-asximr-using-debt-in-a-risky-way","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-imr/imricor-medical-systems-shares/news/is-imricor-medical-systems-asximr-using-debt-in-a-risky-way","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7508","EBIT","BK7503","IMR.AU","BK7007"],"gpt_icon":0},{"id":"2586933752","title":"Imugene Ltd - Collaboration to Advance Oncarlytics and Carteyva Combination in Solid Tumours","url":"https://stock-news.laohu8.com/highlight/detail?id=2586933752","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586933752?lang=en_us&edition=fundamental","pubTime":"2025-11-27 06:08","pubTimestamp":1764194898,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nTUE6YR8Y7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7508","IMU.AU"],"gpt_icon":0},{"id":"2586293378","title":"Imugene Ltd-Strategic Collaboration With Jw Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2586293378","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586293378?lang=en_us&edition=fundamental","pubTime":"2025-11-27 06:08","pubTimestamp":1764194898,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nTUE6YR8Y7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMU.AU","BK7508","BK7067"],"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":1,"totalSize":141,"code":"91000000","status":"200"}]}}